Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Articles, guides, and regulatory updates from our community.
New research suggests thymosin alpha-1 may directly protect neurons via orexin receptor signaling. Learn what this study means for stroke and neuroprotection.
By Peptide Association Research Team
New research suggests thymosin alpha-1 may protect neurons by engaging orexin receptors and suppressing necroptosis. Learn what the study found and its implications.
By Peptide Association Research Team
New research links mitochondrial dysfunction to postoperative cognitive decline. Learn what the science suggests and how emerging therapies may help protect brain health.
By Peptide Association Research Team
New research explores how DNA methylation and the Wnt signaling pathway may influence Alzheimer's disease progression linked to insulin resistance.
By Peptide Association Research Team
New research suggests elamipretide (SS-31) may support recovery after spinal cord injury by preserving mitochondrial function and reducing cell death in animal models.
By Peptide Association Research Team
New research suggests SS-31 (Elamipretide) may modulate alpha-synuclein aggregation and restore mitochondrial function in Parkinson's-related models.
By Peptide Association Research Team
New research explores repurposed drugs targeting Alzheimer's disease pathways. Learn what the latest evidence suggests about emerging therapeutic strategies.
By Peptide Association Research Team
New research suggests elamipretide (SS-31) may support recovery after spinal cord injury by protecting mitochondria and reducing cell death. Learn what the study found.
By Peptide Association Research Team
New research reveals how NAD+ may help restore brain function in Alzheimer's disease through REST protein modulation. Study findings and clinical implications.
By Peptide Association Research Team